Loading resource…

Los Angeles County and University of Southern California (LAC+USC) Medical Center
The article presents a perspective on the shift from intravenous to oral antibiotic therapy, particularly for infections such as bacteremia and osteomyelitis. It highlights the importance of re-evaluating established practices in light of new evidence from randomized clinical trials. The authors argue that oral therapy is not only as effective but also more patient-centered, allowing for quicker recovery and less invasive treatment options. This change is framed as a necessary evolution in infectious disease management.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

World Malaria Report 2020
Same clinical topic · Infectious Disease

PRIMER SYPHILIS
Same clinical topic · Infectious Disease

LEISHMANIASIS
Same clinical topic · Infectious Disease

SUPPLEMENTARY APPENDIX
Same clinical topic · Infectious Disease

Influenza
Same clinical topic · Infectious Disease

VARICELLA ZOSTER VIRUS INFECTION
Same clinical topic · Infectious Disease

RECENT ADVANCES IN THE TREATMENT OF MALARIA
Same clinical topic · Infectious Disease

DEFINING SEPSIS PAST, PRESENT, AND FUTURE
Same clinical topic · Infectious Disease

RAPID DIAGNOSIS OF SEPSIS AND BLOODSTREAM INFECTIONS
Same clinical topic · Infectious Disease